John Garrett is a Registered Nurse and biotech industry professional with a background spanning emergency medicine, intensive care, vascular access, cardiac cath lab medicine, and clinical biomarker science
In all of the blinded clinical trials that studied GLP-1s versus placebo, volunteers injecting placebo (not knowing whether they were injecting drug or placebo), lost weight early in the trials
SeekPeptides members frequently discuss the differences between oral versus injectable tirzepatide and which route produces more tolerable side effects for their individual situation
This projection aligns with Canadian generic pricing models, where generic semaglutide tracker data indicates patients can expect generics priced at roughly 35% of brand-name costs initially, with further reductions as more competitors enter the market
Summary: Weight loss injections are not absolutely contraindicated with gallstones, but require individualised clinical assessment due to increased risk of gallbladder complications during rapid weight loss
